3 Key Checkpoints
- Supplier data are an input to the risk assessment, and responsibility for the assessment lies with the drug manufacturer
- For extractables data, check whether the test conditions represent your own process
- Check sterilization evidence and lot-specific certificates at every receipt
Why Request Documents
For a single-use system (bags, tubing, filters and connectors that are used once and discarded, and their assemblies), material selection, assembly and sterilization take place at the supplier. Because the user cannot see these steps directly, the supporting evidence has to be confirmed through documents. EU GMP Annex 1 (revised 2022, in operation from August 25, 2023) states that supplier assessment is critical to the selection and use of single-use systems, and requires that, for sterilized products, sterility assurance be verified as part of supplier qualification and evidence of sterilization be checked at every receipt. [1][2]
Documents to Request and What They Mean
| Document | What It Shows | Related Standards |
|---|---|---|
| Extractables data | The types and amounts of chemical substances that can be released from the materials under aggressive conditions | USP <665>·<1665>, BioPhorum protocol (2020) [3][4][7] |
| Biological reactivity data | The response the materials produce in cells (in vitro) and in animals (in vivo) | USP <87>, <88> [8][9] |
| Particulate and endotoxin data | Levels of particles and bacterial endotoxins coming from the product | USP <788>, <85> [9][10] |
| Sterilization validation data | Validation of the radiation (gamma, etc.) sterilization process, and evidence that sterilization does not adversely affect performance | ISO 11137, Annex 1 8.133 [1][9][11] |
| Integrity and leak test data | Whether the closure is maintained without holes or leaks | Annex 1 8.132, 8.137 [1][9] |
| Animal-derived component statement (TSE/BSE) | Confirmation that there are no animal-derived components or that the European guidance is met | EMA/410/01 rev.3 [9][12] |
| Lot-specific certificates | Certificate of conformance and evidence of sterilization (irradiation dose) | Annex 1 8.138 [1][9] |
| Shelf-life supporting data | The period for which performance is maintained after sterilization | Supplier validation data [9] |
| Change notification procedure | When, and with what information, planned and unplanned changes are notified | BioPhorum guidance [13][14][19] |
| Quality agreement and audit documents | The responsibilities of both parties, how they communicate, and the supplier's quality system | ICH Q9·Q10 [9][15][16] |
Reading Extractables Data
- USP <665> is the standard for evaluating plastic components used in the manufacture of pharmaceuticals, and it became official on May 1, 2026. It classifies risk as low, moderate or high to set the scope of testing, and <1665> describes the framework for that risk assessment. [3][4][5][6]
- The BioPhorum protocol is an industry standard test method, a 2020 revision of the 2014 edition, and is not a regulatory document. [4][7]
- Supplier data are an input to the user's risk assessment and do not replace the assessment. Annex 1 also requires an evaluation, for each component, of whether the extractables data can be applied to your own process. [1][4]
- ICH Q3E (extractables and leachables), an internationally harmonized guideline, is at the stage where a draft (Step 2b) was published in August 2025. [17][18]
What to Check After Receipt
- At receipt, check and record the outer packaging, labels and accompanying documents (certificate of conformance, evidence of sterilization). [1]
- Check whether the test conditions (solvent, temperature, contact time) represent your own process. [1][19]
- Link change notifications to your own change control procedure. [13][19]
Sources
- European Commission — EudraLex Volume 4, EU GMP Annex 1: Manufacture of Sterile Medicinal Products (August 2022 revision, in operation from 2023-08-25)
- Manufacturing Chemist — What to consider for successful GMP Annex 1 implementation (2023-05-19)
- Labcorp — Preparing for USP <665>: What you need to know (2025-09-02)
- Drug Discovery News — Leachables and extractables in single-use bioprocessing: a compliance guide (2026, no publication date shown)
- Resolian — USP 665 and USP 1665: What Pharma Manufacturers Need to Know (2026)
- ECA Academy — Plastic Components Used in Manufacturing: USP extends Official Date for <665> (2022-03-02)
- BioPhorum — Disposables: Extractables testing of polymeric single-use components used in biopharmaceutical manufacturing (2020-04-22)
- Pharmaceutical Technology — New Standards Define Single-Use Materials Qualification (2018-02-02, Vol. 42 No. 2)
- BioPharm International — Best Practices in Qualification of Single-Use Systems, Weibing Ding (2015-09-01)
- BioProcess International — Complete BPSA Component Quality Test Matrices (2008-05-01)
- ISO (as listed by the Estonian Centre for Standardisation, EVS) — ISO 11137-1:2025 Sterilization of health care products — Radiation — Part 1 (2025 edition, 2025-04-02)
- European Commission / EMA — Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMA/410/01 rev.3, 2011/C 73/01)
- BioProcess International — Management, Notification, and Documentation of Single-Use Systems Change Orders: Challenges and Opportunities, White & Ott (2015-10-15)
- Bioprocess Online (contributed by BioPhorum) — Best Practices For Raw Material Supplier Change Notifications: New BioPhorum Guidance (2021-08-27)
- BioPharm International — Single-use Technology: Balancing the Risks and Rewards, Jerold M. Martin (2011-09-02)
- Bioprocess Online — A Quality Agreement Primer: Reviewing Regulations & Enforcement Activity, Crystal M. Booth (2020-10-09)
- EMA / ICH — ICH Q3E Guideline for extractables and leachables, Step 2b (EMA/CHMP/ICH/236669/2025, 2025-08-18)
- ECA Academy — ICH Q3E Draft Guideline on E&Ls Available (2025-09-10)
- Lab Manager — Managing Single-Use Component Supply Chains: Qualifying Backup Suppliers, Craig Bradley (no publication date shown)
Operated by B2BIO Inc., Bioprocess Division · Report content errors to info@b2bio.co.kr